The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number:3235-0006
Expires:Oct 31, 2018
Estimated average burden
hours per response:23.8

COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
ADURO BIOTECH INCCOM00739L10169,4186,518,100SH SOLE 000
ISHARES TRCORE S&P500 ETF46428720021,27184,099SH SOLE 000
ISHARES TRCORE S&P MCP ETF4642875075,37830,060SH SOLE 000
ISHARES TRCORE S&P SCP ETF4642878044,88765,851SH SOLE 000
ISHARES TRIBOXX HI YD ETF464288513855,4519,637,800SH SOLE 000
POWERSHARES QQQ TRUSTUNIT SER 173935A1045,25436,122SH SOLE 000
PROSHARES TR IISHT VIX ST TRM74347W62711,344121,000SH SOLE 000
SPDR GOLD TRUSTGOLD SHS78463V1079,70079,786SH SOLE 000
VANGUARD INTL EQUITY INDEX FFTSE EMR MKT ETF9220428589,765224,120SH SOLE 000
VANGUARD SPECIALIZED PORTFOLDIV APP ETF9219088443,05432,216SH SOLE 000
VANGUARD TAX MANAGED INTL FDFTSE DEV MKT ETF92194385815,547358,147SH SOLE 000
VANGUARD WORLD FDEXTENDED DUR9219107095,13643,991SH SOLE 000